Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

Affiliations

• ¹ Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
• ² Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
• ³ Molecular Medicine Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Road, New Delhi, India.
• ⁴ Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts, USA.
• ⁵ School of Medicine, University of California, San Diego, 9500 Gilman Drive 0760, La Jolla, California, USA.
• ⁶ Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts, USA.
• ⁷ Department of Chemistry and Department of Molecular Genetics and Microbiology, Duke University, 124 Science Drive, Durham, North Carolina, USA.
• ⁸ Department of Biochemistry and Microbiology, University of Victoria, 270 Petch Hall, Victoria, British Colombia, Canada.
• ⁹ Eskitis Institute for Drug Discovery, Griffith University, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, Australia.
• ¹⁰ Eisai Inc., 4 Corporate Drive, Andover, Massachusetts, USA.
• ¹¹ TropIQ Health Sciences, Geert Grooteplein 28, Huispost 268, Nijmegen, The Netherlands.
• ¹² Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 500 Main Street, Cambridge, Massachusetts, USA.
• ¹³ Eisai Co. Ltd, 5-1-3 Tokodai, Tsukuba, Ibaraki, Japan.
• ¹⁴ Department of Parasitology, Biochemical Primate Research Centre, Rijswijk, The Netherlands.
• ¹⁵ Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA. stuart_schreiber@harvard.edu.
• ¹⁶ Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts, USA. stuart_schreiber@harvard.edu.